News
CAP accreditation
Centogene is excited to announce its successful CAP accreditation. Centogene's continuous improvement of diagnostic processes and its external supervision is the source of benefit to our partners. If you have any requests, please do not hesitate to contact us anytime.
X-linked mental retardation
Mental retardation is a significant impairment of cognitive and adaptive functioning, with onset before age 18 years and it occurs in about 1-3% of the population. Among affected patients, there is historically an increase occurance in males versus females that has long been noted and is generally ...
NGS performed at Centogene
Next Generation Sequencing (NGS) defines an umbrella of new methods for reading nucleotide bases in DNA molecules. NGS was developed to address a need for low-cost high-throughput sequencing technologies in research and diagnostic practices. These methods provide an opportunity ...
Annual report of diagnosed cases
Centogene is proud to present its annual report on diagnosed cases of rare diseases between the period of 01.09.2011 and 31.08.2012. The diagnosis was confirmed genetically by detection of disease-causing mutation(s).We are always enlarging our expertise in molecular genetic diagnostics. Your ...
Single gene establishment Dec 2012
Centogene has established new genes during the last 4 weeks, e.g. AP4M1 for determining SPG50, MOCS1/2 for Molybdenum cofactor deficiency type A/B or CNGA3/CNGB3/GNAT2 for diagnosing correctly Achromatopsia type 2, 3 and 4 to further endorse Centogene’s ophthalmological expertise. Neurological ...
NGS panel establishment Dec 2012
Among Centogene´s panels, Leigh syndrome covers 66 genes and include both nuclear and mitochondrial genes. Despite that, a colon cancer panel is established to offer maximal help to all patients affected with rare types of tumors and malformations related to malignant proliferation as well as ...
New NGS panels
Centogene has increased its NGS panel analyses, covering a wide range of disorders. Correctly identifying these disorders is essential to ensure the appropriate care, that monitoring is provided and to preclude unnecessary testing. Please see below an excerpt of new NGS panels being offered by ...
